LOXO LARO 100 mg (Vitrakvi 100 mg)
Generic Name: larotrectinib
Pill with imprint LOXO LARO 100 mg is White, Capsule-shape and has been identified as Vitrakvi 100 mg. It is supplied by Loxo Oncology, Inc..
Vitrakvi is used in the treatment of solid tumors and belongs to the drug class multikinase inhibitors. Vitrakvi 100 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for LOXO LARO 100 mg
More about Vitrakvi (larotrectinib)
- Side Effects
- During Pregnancy
- Dosage Information
- Imprints, Shape & Color Data
- Drug Interactions
- Pricing & Coupons
- En Español
- 1 Review
- Drug class: multikinase inhibitors
- FDA Approval History
- Vitrakvi (Larotrectinib Capsules)
- Vitrakvi (Larotrectinib Oral Solution)
- Vitrakvi (Advanced Reading)
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.